officialstreetpreachers Subscribe
Published: August 28, 2024

Drug Industry Generates OBSCENE PROFITS From Institutional Lies About Cholesterol & Heart Disease

By The Editor

This article was originally published by Lance D. Johnson at Natural News under the title: Statin Drug Industry Generates OBSCENE PROFITS From Institutional Lies About Cholesterol and the Oversimplification of Heart Disease

Cholesterol, often vilified as the main driver of heart disease, is actually an essential component of cellular health. It plays a crucial role in various biological functions, including building cell membranes, producing hormones, and aiding in the absorption of vitamins. Cholesterol is a necessary nutrient that our bodies cannot produce on their own, so it’s important to get vitamin D from sunlight and to consume foods that contain cholesterol to maintain healthy cholesterol levels.

But today, doctors are indoctrinated and incentivized to push statin drugs on people at an early age, while ignoring all the dietary and lifestyle factors that influence heart disease risk. The oversimplification of the causes of heart disease leads to widespread pill-pushing that benefits a statin drug industry that’s built on a history of lies.

Big Pharma capitalizing on heart disease myths

The pharmaceutical industry has long profited from the widespread belief that high cholesterol is a primary cause of heart disease. This notion has fueled a booming market for statin drugs, which have become a staple of cardiovascular care, forcefully interfering with cholesterol levels. Major pharmaceutical companies, including Pfizer, AstraZeneca, and Merck, have invested heavily in developing and marketing statin medications, reaping substantial financial rewards along the way.

According to Data Bridge Market Research, the U.S. statin market size was valued at $4.53 billion in 2023 and is projected to reach $5.10 billion by 2031. This growth is driven, in part, by the increasing prevalence of high cholesterol among adults, particularly those aged 40-59.

However, the link between high cholesterol and heart disease has been challenged over the past five years, with researchers pointing out manipulated, industry-sponsored

The remainder of this article is available in its entirety at SHTF Plan


Share this Article

Download the Mobile App.
Exit mobile version